ARKG Ark Genomic Revolution Multi-Sector ETF

This is an actively managed fund that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution (“Genomics Revolution Companies”). The Fund may invest in certain companies that the Adviser believes are well-positioned to capitalize on and expected to devote substantial efforts to businesses lines enabled by disruptive genomic innovation, even if such companies do not currently derive a substantial portion of their revenues from genomics related activities.

$64.61  -0.55 (-0.84%)
As of 11/26/2021 13:00:00 EST     IEX book   CBOE book

---

ETF Information

---

Sponsor:     Ark Funds
Category1:  US Equity
Category2:  Single industry
Category3:  Biotechnology
Morningstar category:  Health
Leverage factor:  1.00
Inception date:  10/30/2014
Current yield:  1.22%
Historical average yield:  1.10%
Market cap:  $5,727,564,000
Average volume:  3,008,482
Fees:     0.7500%
Investment style: Actively managed